Previous Next
Studies have suggested the involvement of Th17 cell deregulation in endometriosis, in relation to disease severity. In this study, investigators examined whether IL-23-induced TH17 cells contribute to features of lesion proliferation, vascularization and inflammation in endometriosis using patient samples, representative cell lines and a mouse model of endometriosis. The data reveal deregulation of expression of key genes of the IL-23/Th17 axis in tissue samples and increased IL-23 secretion in the plasma of patients with endometriosis. In the mouse model, treatment targeting IL-23 altered the nature and progression of endometriosis lesions. 

Source(s) :
Danielle J Sisnett et al. The Dysregulated IL-23/TH17 Axis in Endometriosis Pathophysiology. J Immunol. 2024 Mar 11:ji2400018. ;

Last press reviews


COVID-19 and coagulation parameters: a link to mortality?

The COVID-19 pandemic, caused by SARS-CoV-2, has led to millions of deaths...

Resistance training and Multiple Sclerosis: a solution to improve function and quality of life?

Multiple sclerosis (MS) is a chronic autoimmune disease of the central ner...

Endometriosis: the Impact of hormones, sexual practice, and surgical treatments

Endometriosis is a chronic inflammatory disease modulated by estrogen leve...